Article Abstract

National database of patients treated with radical cystectomy provides a current standard and comparison for future technologies

Authors: Kazumasa Matsumoto


Both muscle-invasive bladder cancer and high-risk non-muscle-invasive bladder cancer have been treated using radical cystectomy. Although these aggressive cancers are diseases which depend on radical resection to optimize cancer control, they have been linked to poor prognoses with an estimated 5-year overall survival rate of approximately 60% (1,2).